Authors: Landen, H Moller, M Tillotson, GS Kubin, R Hoffken, G

Citation: H. Landen et al., Clinical experience in Germany of treating community-acquired respiratory infections with the new 8-methoxyfluoroquinolone, moxifloxacin, J INT MED R, 29(2), 2001, pp. 51-60

Authors: Hoffken, G

Citation: G. Hoffken, Is the use of narrow-spectrum antibiotics too narrow-minded in the treatment of severe infections?, CL MICRO IN, 6, 2000, pp. 7-10

Authors: Halank, M Rubens, C Ewert, R Hoffken, G Braun, J

Citation: M. Halank et al., Severe precapillary pulmonary hypertension in suspected antiphospholipid syndrome - partially successful long-term therapy with continuous intravenous iloprost administration, Z RHEUMATOL, 59(5), 2000, pp. 334-342

Authors: Ewert, R Opitz, C Wensel, R Winkler, J Hoffken, G Frank, W Berger, F Kleber, FX Hetzer, R

Citation: R. Ewert et al., Iloprost as inhalative or intravenous long-term treatment of patients withprimary pulmonary hypertension. Register of the Berlin Study Group for Pulmonary Hypertension, Z KARDIOL, 89(11), 2000, pp. 987-999

Authors: Hoffken, G Pasold, R Pfluger, KH Finke, J Fauser, AA Szelenyi, H Wagner, J

Citation: G. Hoffken et al., An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients, J ANTIMICRO, 44(3), 1999, pp. 367-376